Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 969916514a976801-LAX IP: 47.97.18.252 UTC time: 2025-08-03T22:00:19+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif